Single Drug Dose Reversed Autism Symptoms in Mice Fast

Scientists at UCLA Health just made a discovery that could reshape how we think about treating autism: adult brains might be much more flexible than we ever imagined.

The research team found that inflammation during pregnancy caused lasting autism-like changes in mice, including brain overgrowth, sensory sensitivity, repetitive behaviors, and increased seizure risk. But here's the remarkable part: a single dose of the drug rapamycin improved nearly all of these problems in adult mice within about two hours.

The speed of the improvement stunned researchers. Physical changes to the brain typically take weeks or months to develop. These changes happened so fast that the drug couldn't have been repairing brain structure. Instead, it was changing how existing brain circuits functioned.

Dr. Harley Kornblum, who directs the UCLA Intellectual and Developmental Disabilities Research Center, emphasized what this means for future treatments. The rapid response suggests the adult brain remains capable of functional changes even when underlying structural differences from early development persist.

The study, published in Nature Communications, built on earlier research showing that even mild inflammation during pregnancy can affect developing offspring. Previous studies found that children born to mothers who experienced inflammation during pregnancy may have greater likelihood of developing traits associated with autism.

The UCLA team exposed pregnant mice to mild inflammatory stimulus early in pregnancy. The offspring later developed persistent inflammation, brain overgrowth, poorly organized brain communication, and autism-associated behaviors. When researchers gave these adult mice rapamycin, improvements appeared across nearly every measurement within two hours.

Neurons that had been firing unusually returned to normal patterns. The animals became less vulnerable to seizures. Brain regions started communicating more typically. Repetitive behaviors and sensory sensitivity declined.

Why This Inspires

This research offers something families affected by autism desperately need: hope grounded in science. For years, many believed that autism-related brain differences were fixed in early development and couldn't be meaningfully changed in adulthood.

Dr. Janel Le Belle, the study's first author and associate professor in UCLA's Department of Neurosurgery, explained the shift in thinking. If adult brains remain capable of functional improvement, some features of autism might be successfully addressed without needing to correct underlying structural differences.

The researchers stressed that rapamycin itself isn't a practical treatment. The benefits were temporary, repeated use can be toxic, and the study was conducted in mice, not humans. But the rapid response revealed biological processes that could guide development of safer, more targeted therapies.

The drug worked by reducing activity in the mTOR pathway, a biological signaling system that regulates cell growth. Excessive mTOR activity has been linked to some autism-related conditions. Gene analysis showed rapamycin reversed abnormal patterns involving autism, epilepsy, and how neurons fire, with the strongest effects in neurons that stimulate brain activity.

This discovery points scientists toward the brain's functional circuitry, not just its physical structure, as a target for future treatments that could help millions of families worldwide.